AzTrials
AzTrials

Bulimia NervosaNCT06566612

Avoidance-driven Decision Making and Learning in Anorexia Nervosa and Bulimia Nervosa

An observational study of Bulimia Nervosa and Anorexia Nervosa, run by University of California, San Diego at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to investigate areas of the brain responsible for avoidance learning in adults with eating disorders using brain imaging techniques, computer tasks, and self-report questionnaires and interviews. Read more about this study

Who is it for?
Ages 18 to 39 years, women onlyHealthy volunteers can take part
Conditions the study is for
Bulimia Nervosa, Anorexia Nervosa
How many people
78 participants
Where
1 siteUnited States
Study dates
1 Aug 2024to 31 Jul 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 39 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: The study will recruit 52 adult women currently ill with an eating disorder, including anorexia nervosa (AN; n=26) and bulimia nervosa (BN, n=26), and 26 healthy control (HC) women between the ages of 18 and 39.

Who may be able to join

  • Eating Disorder Group:
  • Between the ages of 18 and 39 years old
  • Meet DSM-V criteria for anorexia nervosa or bulimia nervosa
  • Healthy Controls:
  • Between the ages of 18 and 39 years old
  • Have maintained 85% to 120% ideal body weight since menarche

Who cannot join

  • Psychotic illness/other mental illness requiring hospitalization
  • Current dependence on drugs or alcohol defined by DSM IV criteria. Additionally, positive test results for drug use on the day of the scan, apart of marijuana, will result in cancelling or rescheduling the scan because acute use will impact MRI measures.
  • Physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight
  • Neurological disorder, neurodevelopmental disorder, or history of head injury with >30 min loss of consciousness
  • Any contraindication to undergoing an MRI
  • Primary obsessive compulsive disorder or primary major depressive disorder
Show all 12Show fewer
  • Additional Exclusion Criteria for ED Group:
  • If taking other psychotropic medication, any change in dosage in the 2 weeks before scanning
  • Additional Exclusion Criteria for Healthy Control Group:
  • Meet criteria for the diagnosis of any psychiatric disorder currently
  • Any history of binge eating or purging behaviors, including self-induced vomiting, laxative or diuretic misuse
  • Use of any psychoactive or other medication known to affect mood or concentration in the last 3 months

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Christina E Wierenga, PhD contact

858-534-8047

cwierenga@health.ucsd.edu

United States1 site, 1 recruiting
  • UCSD Eating Disorders Treatment and Research Program

    La Jolla, California, 92121

    Sophie R Abber, MS, 858-534-0371, sabber@health.ucsd.edu

    Katherine Gandee, BS, 858-534-0371, kgandee@health.ucsd.edu

    Recruiting

Other trials in United States

About this study

The purpose of this study is to investigate areas of the brain responsible for avoidance learning in adults with eating disorders using brain imaging techniques, computer tasks, and self-report questionnaires and interviews. The investigators will study changes in brain activity using a procedure called functional magnetic resonance imaging (fMRI). This study will include 78 women with an eating disorder (26 with anorexia nervosa [AN], 26 with bulimia nervosa [BN]) and 26 healthy controls (HC) aged 18-39.

Aim 1: Evaluate behavioral differences in active and passive avoidance learning in eating disorders and associations with symptoms.

Read more

Aim 2: Evaluate whether corticostriatal and limbic-prefrontal fMRI BOLD response associated with avoidance learning differs in eating disorders relative to healthy controls and relates to symptoms.

Aim 3: Evaluate whether functional connectivity of avoidance learning neural circuity differs in eating disorders relative to healthy controls.

Medical subject headings
Bulimia Nervosa, Anorexia Nervosa

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06566612
Study groupRoleWhat they receive
Anorexia NervosaParticipants that meet Diagnostic And Statistical Manual Of Mental Disorders (DSM-V) criteria for Anorexia Nervosa.
Bulimia NervosaParticipants that meet DSM-V criteria for Bulimia Nervosa.
Healthy ControlsParticipants that do not meet DSM-V criteria for any disorder.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Learning rate

    Behavioral responses during a card game gambling task

    Measured: 25 minutes

  2. fMRI brain response

    fMRI brain activity associated with the card game gambling task

    Measured: 25 minutes

  3. Brain connectivity

    Whole-brain functional connectivity associated with the card game gambling task

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2024
  2. Study start1 Aug 2024
  3. Primary completion31 Jul 2026 (estimated)
  4. Study completion31 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
78 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06566612
Sponsor's protocol ID
810384
Status last verified
Apr 2026
First submitted
15 Aug 2024
Last updated
1 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Bulimia Nervosa and Anorexia Nervosa, run by University of California, San Diego at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christina E Wierenga, PhD (858-534-8047, cwierenga@health.ucsd.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Learning rate (time frame: 25 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in